Measurement of succinylcholine concentration in human plasma by electrospray tandem mass spectrometry.
An electrospray mass spectrometric method for the quantification of the depolarizing neuromuscular blocking agent succinylcholine (SUX) is described. An extraction method compatible with direct infusion inlet was developed and leads to an analysis cycle time of 7--8 min instead of 25 min that would be required for HPLC inlet. SUX was extracted from human plasma on C1 solid-phase cartridges and was analyzed using positive ion electrospray tandem mass spectrometry (ESI-MS/MS). SUX plasma concentrations were determined by a stable isotope dilution assay using hexadeuterosuccinylcholine diiodide (SUXd6) as the internal standard. The calibration curve was prepared using the ratio of intensities of the major product ions in the collision-induced dissociation spectrum for known concentration ratios of SUX and SUXd6 in plasma. Calibration curves for the quantification were linear from 25 to 4000 ng/ml. For intraday precision, CV were < or =6% and accuracy ranged from 98 to 103%. For the interday precision, CV were < or =10% and accuracy ranged from 90 to 102%. This method is specific, sensitive, reproducible, and practical in a clinical setting.
Faculté de pharmacie, Université de Montréal, 2900 Boulevard Edouard Montpetit, Montréal, Québec H3C 3J7, Canada.
J J
JJ
Roy
D
D
Boismenu
H
H
Gao
O A
OA
Mamer
F
F
Varin
D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003903:Deuterium; D004355:Drug Stability; D006801:Humans; D011786:Quality Control; D012015:Reference Standards; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D013390:Succinylcholine / Q000097:blood*
D003903:Deuterium; D013390:Succinylcholine